Smart MRI tailors cancer therapy for better outcomes
NCT ID NCT07469241
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a personalized approach for people with advanced esophageal cancer that cannot be removed by surgery. Doctors will use MRI scans to guide a custom combination of chemotherapy, radiation, and immunotherapy. The goal is to see if this tailored treatment can help keep the cancer from growing or spreading for at least one year. The study plans to enroll 50 participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug boost the fight against esophageal cancer?
- Can a flexible dosing schedule improve esophageal cancer treatment?
- Experimental combo targets Hard-to-Treat esophageal cancer
- New drug cocktail targets Hard-to-Treat cancers
- New drug YL201 takes on tough esophageal cancer
- New drug cocktail aims to fight tough esophageal cancer